Eledon Pharmaceuticals, Inc. — Income Charts
17 quarters of history · ending 2017-03-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Operating Expenses
Income Breakdown
Revenue
$0
R&D↓-94.0% -$7M
$479K
D&A↓-92.5% -$49K
$4K
Operating Income↑+87.9% +$10M
$-1M
EBITDA↑+87.9% +$10M
$-1M
Other Income/Expense
—
Pretax Income
—
Tax Provision
$0
Net Income↑+88.0% +$10M
$-1M
Effective Tax Rate
—
Deferred Tax Liabilities
—
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
34.0%
ETR State + Local (pp)↓-0.1pts
5.2%
Operating Lease Cost↓-76.4% -$133K
$41K
Income YoY Variation↑+74.3pts
87.9%
Income QoQ Variation↑+66.8pts
63.2%